Profile of salivary gland flow dysfunctions in patients with differentiated thyroid carcinoma submitted to radioiodine therapy

AIM: To evaluate the effects of radioiodine therapy on salivary flow in patients with differentiated thyroid cancer. METHODS: A sample comprising 88 patients submitted to ablation with iodine 131 was included in the study. The patients were submitted to sialometry and evaluation of the presence of xerostomia before, 10 days and 3 months after radioiodine therapy. RESULTS: Xerostomia was observed in 36.4% of the patients before radioiodine therapy, 59.15% at 10 days after therapy, and 25% at 3 months after therapy. Significant differences were observed in non-stimulated salivary flow rates between the second and third evaluations (p<0.020) and in stimulated salivary flow between the first and second evaluations (p<0.010). CONCLUSIONS: The results suggest that changes in salivary flow resulting from radioiodine therapy are more pronounced during the first weeks after treatment and seem to regress after 3 months.

Saved in:
Bibliographic Details
Main Authors: Vieira,Anna Clara Fontes, Rodrigues,Aline Sampaio Lima, Cruz,Maria Carmen Fontoura Nogueira da, Lopes,Fernanda Ferreira
Format: Digital revista
Language:English
Published: Faculdade de Odontologia de Piracicaba - UNICAMP 2013
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-32252013000300004
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1677-32252013000300004
record_format ojs
spelling oai:scielo:S1677-322520130003000042013-10-28Profile of salivary gland flow dysfunctions in patients with differentiated thyroid carcinoma submitted to radioiodine therapyVieira,Anna Clara FontesRodrigues,Aline Sampaio LimaCruz,Maria Carmen Fontoura Nogueira daLopes,Fernanda Ferreira thyroid gland tumors iodine radioisotopes salivary glands saliva xerostomia hyposalivation AIM: To evaluate the effects of radioiodine therapy on salivary flow in patients with differentiated thyroid cancer. METHODS: A sample comprising 88 patients submitted to ablation with iodine 131 was included in the study. The patients were submitted to sialometry and evaluation of the presence of xerostomia before, 10 days and 3 months after radioiodine therapy. RESULTS: Xerostomia was observed in 36.4% of the patients before radioiodine therapy, 59.15% at 10 days after therapy, and 25% at 3 months after therapy. Significant differences were observed in non-stimulated salivary flow rates between the second and third evaluations (p<0.020) and in stimulated salivary flow between the first and second evaluations (p<0.010). CONCLUSIONS: The results suggest that changes in salivary flow resulting from radioiodine therapy are more pronounced during the first weeks after treatment and seem to regress after 3 months.info:eu-repo/semantics/openAccessFaculdade de Odontologia de Piracicaba - UNICAMPBrazilian Journal of Oral Sciences v.12 n.3 20132013-09-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-32252013000300004en10.1590/S1677-32252013000300004
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Vieira,Anna Clara Fontes
Rodrigues,Aline Sampaio Lima
Cruz,Maria Carmen Fontoura Nogueira da
Lopes,Fernanda Ferreira
spellingShingle Vieira,Anna Clara Fontes
Rodrigues,Aline Sampaio Lima
Cruz,Maria Carmen Fontoura Nogueira da
Lopes,Fernanda Ferreira
Profile of salivary gland flow dysfunctions in patients with differentiated thyroid carcinoma submitted to radioiodine therapy
author_facet Vieira,Anna Clara Fontes
Rodrigues,Aline Sampaio Lima
Cruz,Maria Carmen Fontoura Nogueira da
Lopes,Fernanda Ferreira
author_sort Vieira,Anna Clara Fontes
title Profile of salivary gland flow dysfunctions in patients with differentiated thyroid carcinoma submitted to radioiodine therapy
title_short Profile of salivary gland flow dysfunctions in patients with differentiated thyroid carcinoma submitted to radioiodine therapy
title_full Profile of salivary gland flow dysfunctions in patients with differentiated thyroid carcinoma submitted to radioiodine therapy
title_fullStr Profile of salivary gland flow dysfunctions in patients with differentiated thyroid carcinoma submitted to radioiodine therapy
title_full_unstemmed Profile of salivary gland flow dysfunctions in patients with differentiated thyroid carcinoma submitted to radioiodine therapy
title_sort profile of salivary gland flow dysfunctions in patients with differentiated thyroid carcinoma submitted to radioiodine therapy
description AIM: To evaluate the effects of radioiodine therapy on salivary flow in patients with differentiated thyroid cancer. METHODS: A sample comprising 88 patients submitted to ablation with iodine 131 was included in the study. The patients were submitted to sialometry and evaluation of the presence of xerostomia before, 10 days and 3 months after radioiodine therapy. RESULTS: Xerostomia was observed in 36.4% of the patients before radioiodine therapy, 59.15% at 10 days after therapy, and 25% at 3 months after therapy. Significant differences were observed in non-stimulated salivary flow rates between the second and third evaluations (p<0.020) and in stimulated salivary flow between the first and second evaluations (p<0.010). CONCLUSIONS: The results suggest that changes in salivary flow resulting from radioiodine therapy are more pronounced during the first weeks after treatment and seem to regress after 3 months.
publisher Faculdade de Odontologia de Piracicaba - UNICAMP
publishDate 2013
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-32252013000300004
work_keys_str_mv AT vieiraannaclarafontes profileofsalivaryglandflowdysfunctionsinpatientswithdifferentiatedthyroidcarcinomasubmittedtoradioiodinetherapy
AT rodriguesalinesampaiolima profileofsalivaryglandflowdysfunctionsinpatientswithdifferentiatedthyroidcarcinomasubmittedtoradioiodinetherapy
AT cruzmariacarmenfontouranogueirada profileofsalivaryglandflowdysfunctionsinpatientswithdifferentiatedthyroidcarcinomasubmittedtoradioiodinetherapy
AT lopesfernandaferreira profileofsalivaryglandflowdysfunctionsinpatientswithdifferentiatedthyroidcarcinomasubmittedtoradioiodinetherapy
_version_ 1756427703761764352